tirzepatide phase 3 trial 80 weeks weight change New retatrutide data just dropped π Eli Lilly's reported average loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats: β’ 70 Pounds Gone: The New
Description
Yes, GLP-1 receptor agonists should be discontinued before elective surgery due to the risk of pulmonary aspiration from delayed gastric emptying, despite th...

Some Mounjaro users may experience side effects such as constipation
Researchers Say This Popular Weight-Loss Drug Can Keep You Slim for 3 Years and Counting

"It's a really exciting time," one said.

Swedish university Karolinska Institutet is calling for controlled clinical trials to be conducted to confirm the results.

Which GLP-1 Is Best For Weight Loss